Salt metathesis for developing injectable supramolecular metallohydrogelators as a multi-drug-self-delivery systemElectronic supplementary information (ESI) available. CCDC 1498320-1498326. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6cc07712a

Salt metathesis has been exploited to generate a series of non-steroidal anti-inflammatory drug (NSAID) based Zn( ii ) metallohydrogels displaying both anti-inflammatory and anti-bacterial properties. Relatively low cytotoxicity, rheoreversibility and injectibility of one of these hydrogels make it...

Full description

Saved in:
Bibliographic Details
Main Authors: Roy, Rajdip, Bhagyalalitha, Meduri, Choudhury, Pritam, Dastidar, Parthasarathi
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Salt metathesis has been exploited to generate a series of non-steroidal anti-inflammatory drug (NSAID) based Zn( ii ) metallohydrogels displaying both anti-inflammatory and anti-bacterial properties. Relatively low cytotoxicity, rheoreversibility and injectibility of one of these hydrogels make it suitable for multi-drug-self-delivery application. Salt metathesis has been exploited to generate a series of non-steroidal anti-inflammatory drug (NSAID) based Zn( ii ) metallohydrogels displaying both anti-inflammatory and anti-bacterial properties.
ISSN:1359-7345
1364-548X
DOI:10.1039/c6cc07712a